Prof Research published a new market report on soft tissue allograft. It presents the largest 9 manufacturers in the soft tissue allograft market. The report is a professional and in-depth study on the current state of the global soft tissue allograft market. The report provides key statistics on the market of soft tissue allograft. It is a valuable source of guidance and direction for companies and individuals interested in the soft tissue allograft industry.

The global soft tissue allograft market was valued to be 2,476.11 million USD in 2020. The soft tissue allograft production value is anticipated to have grown with a CAGR of 4.42% in the coming years to reach 3,210.53 million USD in 2026.

Zimmer Biomet is the largest manufacturer of soft tissue allografts in the world, it has a market share of 23.32% in value. Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues.

Johnson & Johnson is the second-largest manufacturer of soft tissue allograft in the world, it has a market share of 19.85% in value. Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices.

Allergan is the third-largest manufacturer of soft tissue allograft in the world, it has a market share of 15.3% in value. Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. In June 2019, U.S. pharmaceutical company AbbVie acquired Allergan.

MiMedix Group is the fourth largest manufacturer of soft tissue allograft in the world, it has a market share of 10.03% in value. MiMedx is an industry leader in utilizing birth tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare.